Literature DB >> 28986649

[Mesothelioma].

I Tischoff1, A Tannapfel2.   

Abstract

Malignant mesotheliomas are rare and aggressive tumours arising from mesothelial cells of the pleura and peritoneum. Infrequent sites of origin are the pericardium and tunica vaginalis testis. More than 80% of mesotheliomas are localized in the pleura. Men are more frequently affected than women. The median age is >60 years. Asbestos exposure is the best known aetilogical risk factor and is reported in 54-90% of patients. In Germany, malignant mesotheliomas caused by occupational asbestos exposure are compensated as occupational disease since 1977. Several neoplastic and non-neoplastic lesions like metastasis, sarcomas, lymphomas or pleuritis with reactive mesothelial proliferation have to be distinguished from malignant mesotheliomas. Especially, the pathohistological differentiation between atypical reactive mesothelial proliferation from malignant mesothelioma is a diagnostic challenge.

Entities:  

Keywords:  Asbestos; Differential diagnosis; Lung dust analysis; Occupational disease; Pleura neoplasms

Mesh:

Substances:

Year:  2017        PMID: 28986649     DOI: 10.1007/s00292-017-0364-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  18 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Loss of expression of BAP1 predicts longer survival in mesothelioma.

Authors:  Mahtab Farzin; Christopher W Toon; Adele Clarkson; Loretta Sioson; Nicole Watson; Juliana Andrici; Anthony J Gill
Journal:  Pathology       Date:  2015-06       Impact factor: 5.306

3.  Pleural and peritoneal mesotheliomas in the Friuli Venezia Giulia register: data analysis from 1995 to 2015 in Northeastern Italy.

Authors:  Flavia D'Agostin; Paola De Michieli; Carolin Chermaz; Corrado Negro
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

Authors:  Aliya Noor Husain; Thomas V Colby; Nelson G Ordóñez; Timothy Craig Allen; Richard Luther Attanoos; Mary Beth Beasley; Kelly Jo Butnor; Lucian R Chirieac; Andrew M Churg; Sanja Dacic; Françoise Galateau-Sallé; Allen Gibbs; Allen M Gown; Thomas Krausz; Leslie Anne Litzky; Alberto Marchevsky; Andrew G Nicholson; Victor Louis Roggli; Anupama K Sharma; William D Travis; Ann E Walts; Mark R Wick
Journal:  Arch Pathol Lab Med       Date:  2017-07-07       Impact factor: 5.534

Review 5.  Pathohistological diagnosis and differential diagnosis.

Authors:  Iris Tischoff; Matthias Neid; Volker Neumann; Andrea Tannapfel
Journal:  Recent Results Cancer Res       Date:  2011

6.  Incidence of malignant mesothelioma in Germany 2009-2013.

Authors:  Martin Lehnert; Klaus Kraywinkel; Evelyn Heinze; Thorsten Wiethege; Georg Johnen; Julia Fiebig; Thomas Brüning; Dirk Taeger
Journal:  Cancer Causes Control       Date:  2016-12-27       Impact factor: 2.506

Review 7.  Deciduoid mesothelioma: a report of 5 cases and literature review.

Authors:  Jinru Shia; Robert A Erlandson; David S Klimstra
Journal:  Ultrastruct Pathol       Date:  2002 Nov-Dec       Impact factor: 1.094

8.  [Pathologic and anatomic evidence of peritoneal metastases].

Authors:  I Tischoff; A Tannapfel
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

9.  Comparison of genomic abnormality in malignant mesothelioma by the site of origin.

Authors:  Maiko Takeda; Takahiko Kasai; Yasunori Enomoto; Masato Takano; Kohei Morita; Tokiko Nakai; Norishige Iizuka; Hiroshi Maruyama; Chiho Ohbayashi
Journal:  J Clin Pathol       Date:  2014-09-12       Impact factor: 3.411

10.  BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.

Authors:  Michele Carbone; Laura Korb Ferris; Francine Baumann; Andrea Napolitano; Christopher A Lum; Erin G Flores; Giovanni Gaudino; Amy Powers; Peter Bryant-Greenwood; Thomas Krausz; Elizabeth Hyjek; Rachael Tate; Joseph Friedberg; Tracey Weigel; Harvey I Pass; Haining Yang
Journal:  J Transl Med       Date:  2012-08-30       Impact factor: 5.531

View more
  3 in total

1.  Asbestos danger in central Europe is not yet over - the situation in the Czech Republic.

Authors:  Miroslav Urban; Daniela Pelclová; Pavel Urban; Michael Vít; Peter Urban; Zdenka Fenclová
Journal:  Cent Eur J Public Health       Date:  2022-06       Impact factor: 1.154

2.  Primary malignant peritoneal mesothelioma mimicking tuberculous peritonitis: A case report.

Authors:  Li-Cheng Lin; Wen-Yen Kuan; Bei-Hao Shiu; Yu-Ting Wang; Wan-Ru Chao; Chi-Chih Wang
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

3.  Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.

Authors:  Claudia Baron; Marie Buchholz; Britta Majchrzak-Stiller; Ilka Peters; Daniel Fein; Thomas Müller; Waldemar Uhl; Philipp Höhn; Johanna Strotmann; Chris Braumann
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.